Few stocks have generated as much excitement in 2017 as 22nd Century Group (NYSEMKT: XXII). Shares of the plant biotechnology company nearly tripled in price by mid-September. While some of those gains were given up, 22nd Century Group stock is still up more than 150% year to date.
But why has this small-cap stock captured investors’ attention? And what are the prospects for the company? Here are three things you really need to know about 22nd Century Group.
Image source: Getty Images.